Literature DB >> 12788841

Pharmacological therapy of obesity: past, present, and future.

David S Weigle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12788841     DOI： 10.1210/jc.2003-030151

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  14 in total

Review 1.  Current and novel approaches to the drug therapy of obesity.

Authors:  Jean-Philippe Chaput; Angelo Tremblay
Journal:  Eur J Clin Pharmacol       Date:  2006-08-26       Impact factor: 2.953

2.  Bariatric surgery: the past, present, and future.

Authors:  Alan A Saber; Mohamed H Elgamal; Michael K McLeod
Journal:  Obes Surg       Date:  2007-12-08       Impact factor: 4.129

3.  Intragastric injection of botulinum toxin for the treatment of obesity. Where are we?

Authors:  Diego Garcia-Compean; Hector Maldonado Garza
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

4.  Inhibitory effects of corni fructus extract on angiogenesis and adipogenesis.

Authors:  Jae-Ho Hwang; Jong-Deog Kim
Journal:  Korean J Physiol Pharmacol       Date:  2011-02-28       Impact factor: 2.016

Review 5.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.

Authors:  Soona Shin; Junko Wakabayashi; Melinda S Yates; Nobunao Wakabayashi; Patrick M Dolan; Susan Aja; Karen T Liby; Michael B Sporn; Masayuki Yamamoto; Thomas W Kensler
Journal:  Eur J Pharmacol       Date:  2009-08-19       Impact factor: 4.432

Review 7.  Obesity pharmacotherapy: current perspectives and future directions.

Authors:  Monika Misra
Journal:  Curr Cardiol Rev       Date:  2013-02-01

8.  The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents.

Authors:  Sonia A Tucci; Emma J Boyland; Jason Cg Halford
Journal:  Diabetes Metab Syndr Obes       Date:  2010-05-10       Impact factor: 3.168

9.  Pancreatic lipase inhibitory activity of taraxacum officinale in vitro and in vivo.

Authors:  Jian Zhang; Min-Jung Kang; Myung-Jin Kim; Mi-Eun Kim; Ji-Hyun Song; Young-Min Lee; Jung-In Kim
Journal:  Nutr Res Pract       Date:  2008-12-31       Impact factor: 1.926

10.  A pharmacological analysis of stimulant-induced increases in smoking.

Authors:  Andrea R Vansickel; William W Stoops; Paul E A Glaser; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2007-04-20       Impact factor: 4.415
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.